In conclusion, we described noncoding mutations within the TERT and DPH3 promoter at high frequency in BCC tumors in addition to frequent alterations in PTCH1 and TP53 genes that impair protein functions. This evidence concerns the gene TERT and skin basal cell carcinoma.